Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis P Garrison

Showing results (131-140 of 190) with videos related to

Pageof 19
Sort By:
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 12, 2015
The clinical and cost burden of coronary calcification in a Medicare cohort: An economic model to address under-reporting and misclassificationLouis P Garrison, Jack Lewin, Christopher H Young, et al.
Drug Metabolism Reviews|May 9, 2008
A review of public policy issues in promoting the development and commercialization of pharmacogenomic applications: challenges and implicationsLouis P Garrison, Rick J Carlson, Josh J Carlson, et al.
The American Journal of Managed Care|April 14, 2006
Toward evidence-based assessment for coverage and reimbursement of laboratory-based diagnostic and genetic testsScott D Ramsey, David L Veenstra, Louis P Garrison, et al.
Drug Safety|June 18, 2016
Active Surveillance versus Spontaneous Reporting for First-Line Antiretroviral Medicines in Namibia: A Cost-Utility AnalysisMarita Mann, Assegid Mengistu, Johannes Gaeseb, et al.
The American Journal of Managed Care|March 23, 2012
Systematic review of comparative effectiveness data for oncology orphan drugsMindy M Cheng, Scott D Ramsey, Emily Beth Devine, et al.
Plos One|February 25, 2012
Potential cost-effectiveness of universal access to modern contraceptives in UgandaJoseph B Babigumira, Andy Stergachis, David L Veenstra, et al.
BMC Public Health|December 8, 2011
Estimating the costs of induced abortion in Uganda: a model-based analysisJoseph B Babigumira, Andy Stergachis, David L Veenstra, et al.
Advances in Therapy|March 24, 2026
Estimating the Impact of Hemophilia A Treatment Administration on Patient Health Utility: Combining a Discrete Choice Experiment with Time Trade-Off MethodMelody S Benton, Dongzhe Hong, Mark W Skinner, et al.
Plos One|April 6, 2011
Cost effectiveness of a pharmacy-only refill program in a large urban HIV/AIDS clinic in UgandaJoseph B Babigumira, Barbara Castelnuovo, Andy Stergachis, et al.
Expert Review of Anti-Infective Therapy|December 8, 2010
Pharmaceutical interventions for mitigating an influenza pandemic: modeling the risks and health-economic impactsMaarten J Postma, George Milne, E Anthony S Nelson, et al.
Pageof 19

Showing results (131-140 of 190) with videos related to

Sort By:
Pageof 19
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 12, 2015
The clinical and cost burden of coronary calcification in a Medicare cohort: An economic model to address under-reporting and misclassificationLouis P Garrison, Jack Lewin, Christopher H Young, et al.
Drug Metabolism Reviews|May 9, 2008
A review of public policy issues in promoting the development and commercialization of pharmacogenomic applications: challenges and implicationsLouis P Garrison, Rick J Carlson, Josh J Carlson, et al.
The American Journal of Managed Care|April 14, 2006
Toward evidence-based assessment for coverage and reimbursement of laboratory-based diagnostic and genetic testsScott D Ramsey, David L Veenstra, Louis P Garrison, et al.
Drug Safety|June 18, 2016
Active Surveillance versus Spontaneous Reporting for First-Line Antiretroviral Medicines in Namibia: A Cost-Utility AnalysisMarita Mann, Assegid Mengistu, Johannes Gaeseb, et al.
The American Journal of Managed Care|March 23, 2012
Systematic review of comparative effectiveness data for oncology orphan drugsMindy M Cheng, Scott D Ramsey, Emily Beth Devine, et al.
Plos One|February 25, 2012
Potential cost-effectiveness of universal access to modern contraceptives in UgandaJoseph B Babigumira, Andy Stergachis, David L Veenstra, et al.
BMC Public Health|December 8, 2011
Estimating the costs of induced abortion in Uganda: a model-based analysisJoseph B Babigumira, Andy Stergachis, David L Veenstra, et al.
Advances in Therapy|March 24, 2026
Estimating the Impact of Hemophilia A Treatment Administration on Patient Health Utility: Combining a Discrete Choice Experiment with Time Trade-Off MethodMelody S Benton, Dongzhe Hong, Mark W Skinner, et al.
Plos One|April 6, 2011
Cost effectiveness of a pharmacy-only refill program in a large urban HIV/AIDS clinic in UgandaJoseph B Babigumira, Barbara Castelnuovo, Andy Stergachis, et al.
Expert Review of Anti-Infective Therapy|December 8, 2010
Pharmaceutical interventions for mitigating an influenza pandemic: modeling the risks and health-economic impactsMaarten J Postma, George Milne, E Anthony S Nelson, et al.
Pageof 19